Speculators only, and I'm not trying to pump, buyers elsewhere will be what makes this one go or not.
The risk is to the old trading range or just above $1.25. Even if the September trial fails PRAN has the second chance (AD) and even PB434.
Buy because: ...a quiet base is being formed (after news it may be too late)
........timing is about right with TWO important trials going on
.........the science? I don't know but have not seen it refuted
..........much cash has already been raised (some shares to be sold until month's end)
..........upside potential is staggering
..........preliminary trial information affirms the drug's safety
A year later. I think this was my only buy suggestion on the board. At $2.23 the risk was so so small. Now PRAN is a real company but risk is much higher. But REWARDS could still dwarf those of the last year.
Wednesday is a decent volume day so far. Somebody is accumulating at $2.20 (orders are added each time some are executed). Too bad the buyer doesn't bid higher. In about two weeks we'll know how the dilution sale went..
That will still be a market cap of $700M. Look at ACAD, it is already a billion. PRAN could be worth several billions, IF successful.
I had 10K ACAD at 0.70 a couple of years back. Sold for 2.50 (350% gain) and now look at. I dont want to make the same mistake with PRAN. IF the trial is successful no telling where the SP will go.